UnitedHealth Group Incorporated (NYSE:UNH) had its target price boosted by Morgan Stanley from $215.00 to $235.00 in a research note issued to investors on Wednesday morning. Morgan Stanley currently has an overweight rating on the healthcare conglomerate’s stock.
UNH has been the topic of several other reports. UBS AG reiterated an overweight rating on shares of UnitedHealth Group in a report on Thursday, August 24th. BidaskClub raised shares of UnitedHealth Group from a buy rating to a strong-buy rating in a research report on Saturday, July 8th. Bank of America Corporation increased their price target on shares of UnitedHealth Group from $210.00 to $214.00 and gave the company a buy rating in a research report on Friday, July 14th. Zacks Investment Research lowered shares of UnitedHealth Group from a buy rating to a hold rating in a research report on Tuesday, September 26th. Finally, ValuEngine lowered shares of UnitedHealth Group from a buy rating to a hold rating in a research report on Thursday, October 5th. Three analysts have rated the stock with a hold rating and twenty-four have issued a buy rating to the company’s stock. The company presently has an average rating of Buy and a consensus price target of $215.27.
UnitedHealth Group (NYSE UNH) traded down 0.70% during midday trading on Wednesday, hitting $203.80. 2,443,443 shares of the stock traded hands. UnitedHealth Group has a 52-week low of $133.03 and a 52-week high of $207.80. The firm’s 50-day moving average is $196.96 and its 200-day moving average is $185.50. The company has a market cap of $201.56 billion, a price-to-earnings ratio of 23.14 and a beta of 0.63.
UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.57 by $0.09. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. The company had revenue of $50.32 billion for the quarter, compared to analysts’ expectations of $50.38 billion. During the same period in the prior year, the business earned $2.17 EPS. The firm’s quarterly revenue was up 8.7% on a year-over-year basis. Analysts predict that UnitedHealth Group will post $9.91 EPS for the current year.
ILLEGAL ACTIVITY NOTICE: This piece was first published by StockNewsTimes and is the property of of StockNewsTimes. If you are accessing this piece on another publication, it was copied illegally and reposted in violation of United States & international copyright law. The correct version of this piece can be read at https://stocknewstimes.com/2017/10/19/unitedhealth-group-incorporated-unh-given-new-235-00-price-target-at-morgan-stanley.html.
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 19th. Stockholders of record on Friday, September 8th were paid a dividend of $0.75 per share. The ex-dividend date was Thursday, September 7th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.46%. UnitedHealth Group’s payout ratio is 33.26%.
In other news, Director William C. Ballard, Jr. sold 5,000 shares of the firm’s stock in a transaction that occurred on Thursday, August 3rd. The shares were sold at an average price of $193.98, for a total transaction of $969,900.00. Following the sale, the director now owns 76,058 shares of the company’s stock, valued at approximately $14,753,730.84. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Larry C. Renfro sold 50,574 shares of the firm’s stock in a transaction that occurred on Friday, September 15th. The stock was sold at an average price of $198.11, for a total transaction of $10,019,215.14. Following the sale, the insider now directly owns 195,625 shares in the company, valued at approximately $38,755,268.75. The disclosure for this sale can be found here. Insiders have sold a total of 76,174 shares of company stock worth $14,981,909 in the last ninety days. Corporate insiders own 0.89% of the company’s stock.
Several hedge funds and other institutional investors have recently modified their holdings of the company. Regal Wealth Group Inc. grew its stake in UnitedHealth Group by 0.4% in the 2nd quarter. Regal Wealth Group Inc. now owns 746 shares of the healthcare conglomerate’s stock valued at $138,000 after acquiring an additional 3 shares during the period. Jackson Grant Investment Advisers Inc. grew its stake in UnitedHealth Group by 0.4% in the 1st quarter. Jackson Grant Investment Advisers Inc. now owns 1,097 shares of the healthcare conglomerate’s stock valued at $180,000 after acquiring an additional 4 shares during the period. RB Capital Management LLC grew its stake in UnitedHealth Group by 0.4% in the 2nd quarter. RB Capital Management LLC now owns 1,732 shares of the healthcare conglomerate’s stock valued at $321,000 after acquiring an additional 7 shares during the period. Altfest L J & Co. Inc. grew its stake in UnitedHealth Group by 0.3% in the 2nd quarter. Altfest L J & Co. Inc. now owns 2,963 shares of the healthcare conglomerate’s stock valued at $549,000 after acquiring an additional 10 shares during the period. Finally, Parkside Financial Bank & Trust grew its stake in UnitedHealth Group by 1.4% in the 1st quarter. Parkside Financial Bank & Trust now owns 854 shares of the healthcare conglomerate’s stock valued at $140,000 after acquiring an additional 12 shares during the period. 86.11% of the stock is currently owned by institutional investors and hedge funds.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.